Author correction to‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’[Acta Pharmaceutica Sinica B 13(2023)2138-2151]

查看全文 作　　者：Wei [1]Wei;Qingxuan [1]Zeng;Yan [1]Wang;Xixi [1]Guo;Tianyun [1]Fan;Yinghong [1]Li;Hongbin [1]Deng;Liping [1]Zhao;Xintong [1]Zhang;Yonghua [1]Liu;Yulong [1]Shi;Jingyang [1]Zhu;Xican [1]Ma;Yanxiang [1]Wang;Jiandong [1]Jiang;Danqing [1]Song 机构地区：[1]Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China 出　　处：《Acta Pharmaceutica Sinica B》索引2024年第14卷第3期,共1页 摘　　要：The authors regret that there are some misplaced figure numbers in the body of this article due to negligence in the layout and proofreading of the figures.Although it does not affect the conclusion,it is an obvious error.The authors have now modified as below.The authors apologize for any inconvenience caused to the journal and readers. 关 键 词：journal CORRECTION CONCLUSION